only with
Nectar Lifesciences Ltd.
Nectar Lifesciences
Nectar Lifesciences Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap - With a market cap of ₹2.24 Cr.
Subsidiaries
No Subsidiaries Data available
Management
Contact Information
Company Address
Registrar
Company Profile
Nectar Lifesciences (Nectar) is a research-driven, leading manufacturer of Active Pharmaceutical Ingredients (API), intermediates as well as Finished dosage forms offering largest segment of anti-infectives namely Cephalosporins. Nectar has proven to be a reliable CMO (Contract Manufacturing Organization) to global pharma innovators. Nectar has leading global capacities in Cephalosporin antibiotics such as Cefixime, Cefuroxime Axetil Amorphous, Cefuroxime Axetil Crystalline, Cefotaxime Sodium, Ceftriaxone Sodium.
The company is the world’s leading producer of Cefixime Trihydrate, Cefuroxime Axetil, Cefpodoxime Proxetil and Sterile APIs. All of the company’s plants can be converted to multi-purpose plants based on product basket requirement.
Business area of the company
Nectar is a global pharmaceutical company specializing in Cephalosporins.
Products
Oral Cephalosporins:
- Cefixime
- Cefurozime Axetil Crystalline
- Cefuroxime Axetil Amorphous
- Cedpodoxime Proxetil
- Cefprozil
- Cefdinir
Sterile Cephalosporins:
- Cefotaxime Sodium
- Ceftriaxone Sodium
- Cefuroxime Sodium
- Cefazolin Sodium
- Ceftazidime pentahydrate
- Cefepime +Arginine